Getting insurance after genetic screening on famil... Catalogue en ligne

Titre :	Getting insurance after genetic screening on familial hypercholesterolaemia ; the need to educate both insurers and the public to increase adherence to national guidelines in the Netherlands. (2002)
Auteurs :	P.J. MARANG-VAN DE MHEEN ; M.E.A. STOUTHARD ; M.C. VAN MAARLE ; Department of Social Medicine. Academic Medical Centre. Amsterdam. NLD
Type de document :	Article
Dans :	Journal of epidemiology and community health (vol. 56, n° 2, 2002)
Pagination :	145-147
Langues:	Anglais
Mots-clés :	Hypercholestérolémie ; Maladie héréditaire ; Dépistage ; Assurance maladie ; Protection sociale ; Recommandation ; Projet loi ; Europe ; Homme ; Lipide ; Métabolisme [pathologie] ; Hyperlipoprotéinémie ; Pays Bas
Résumé :	[BDSP. Notice produite par INIST-CNRS 8aPR0xZF. Diffusion soumise à autorisation]. Heterozygous familial hypercholesterolaemia (FH) is a common autosomal dominant inherited metabolic disease with a prevalence of 1 in 500 in most Western countries. 1-3 People with FH experience an increased risk for coronary artery disease (CAD) and excess mortality especially at a young age. 4 5 Until recently the diagnosis of FH was based on clinical signs and symptoms alone. These included increased cholesterol concentrations, in particular of LDL-cholesterol, in combination with the presence of tendon xanthoma, corneal arcus, xanthelasmata and a history of early CAD. Frequently FH was diagnosed after a first cardiac event.

PORTAIL DOCUMENTAIRE